Abstract
purpose. Effects of brain-derived neurotrophic factor (BDNF) and neurotrophin
(NT)-4 on retinal ganglion cells (RGCs) isolated and cultured in a
serum-free medium are evaluated objectively by using flow cytometry.
methods. RGCs from the retinas of 2-day-old rats were isolated in a two-step
panning and cultured in a serum-free medium. BDNF (1, 10, and 100 pg/ml
or 1, 10, and 100 ng/ml), NT-4 (0.1, 1, 10, and 100 ng/ml) or their
vehicle, phosphate-buffered saline, were individually added to aliquots
of the medium to be cultured for 48 hours. Then, after adding
5-chloromethylfluorescein diacetate, the survival of RGCs was evaluated
using flow cytometry.
results. The method used allowed the authors to analyze 10,000 RGCs per
sample in approximately 2 minutes, so that a much larger number of
cells was evaluated in a shorter period than with previously reported
methods. RGCs were classified into either large or small RGCs, and the
survival of each of these groups was determined objectively by the
amount of fluorescent emission. BDNF improved the survival rate of RGCs
concentration-dependently. In particular, the survival rate of small
RGCs was greatly improved. BDNF at 100 ng/ml increased the survival
rate of small RGCs by 17.4% and that of large RGCs by 7.8% in
comparison to the controls. NT-4 did not significantly improve the
survival rates of either large or small RGCs.
conclusions. BDNF improved the survival rate of RGCs, particularly of small RGCs,
concentration-dependently, but NT-4 had little influence on the
survival rate. The current method was useful in evaluating the effects
of neuroprotective factors or neurotoxic factors on cultured
RGCs.
In recent years, retinal ganglion cells (RGCs) have been isolated
with immunologic methods,
1 and new findings have been
reported.
2 3 However, in the previous reports, RGCs have
been evaluated microscopically with relatively small numbers of cells
and subjective judgment. Therefore, a more objective and accurate
evaluation has been sought.
Brain-derived neurotrophic factor (BDNF) discovered in 1975 is one of
the most important neurotrophic factors and is involved in the
classification and survival of neurons.
4 5 6 7 8 9 It has been
reported that BDNF improved RGC survival in vitro and that BDNF
suppressed RGC loss in axotomized animals and in the ocular
hypertensive model.
6 7 10 Neurotrophin (NT)-4 is another
major neurotrophic factor that has been reported to increase the RGC
survival rate and is involved in retinal development, but these results
are not necessarily consistent.
5 8 11 12 13 14
Rat RGCs have been classified into subgroups by their cell
size,
2 7 15 and RGCs of different sizes had different
susceptibilities to the loading conditions of these
factors.
7 However, it has been difficult to evaluate
precisely the effects of loading conditions on RGCs separated by their
cell size.
Flow cytometry has been recently developed to analyze cells very
quickly and objectively. Cells can be rapidly separated according to
their size, cell cycle, and other parameters with this method.
In the present study, isolated RGCs cultured in serum-free medium were
subject to flow cytometric analysis to investigate quantitatively and
objectively the neurotrophic effects of BDNF and NT-4 on RGCs.
Culture plates were coated with 0.1 mg/ml of polyornithine (Sigma
Chemical Co., St. Louis, MO) for 5 hours or longer and then coated
overnight with 5 μg/ml of EHS-laminin (Upstate Biotechnology, Lake
Placid, NY). The medium developed by Politi et
al.16 for monolayer culture of mixed mouse retinal
neurons was modified for use in this experiment. The medium used was
Dulbecco’s modified Eagle’s medium to which the following were added:
insulin (1.6 × 10−6 M), progesterone
(4.0 × 10−8 M), selenite (6.0 ×
10−8 M), transferrin (12.5 ×
10−8 M), putrescine (2 ×
10−4 M), hydrocortisone (1.0 ×
10−7 M), cytidine-5′-diphosphocholine (5.2 × 10−6 M) and cytidine-5′-diphosphoethanolamine
(2.9 × 10−6 M). The seeding density was
1200 cells/mm2. The cells were incubated at
37°C in humidified 10% CO2 and 90% air.
BDNF or NT-4, 10 μl, was added to each well containing RGCs, after
preparation with phosphate-buffered saline (PBS) to make final
concentrations of 1, 10, and 100 pg/ml and 1, 10, and 100 ng/ml for
BDNF or 0.1, 1, 10, and 100 ng/ml for NT-4, respectively. As the
control, 10 μl PBS without neurotrophic factors was added to each
well.
After incubation for 48 hours, cells were treated for 10 minutes,
keeping the same culture condition with 5-chloromethylfluorescein
diacetate (Molecular Probes, Inc., Eugene, OR). After the reaction, the
cells were detached from the culture dish by gently pipetting 20 to 30
times. To avoid cell damage as much as possible, pipetting was
performed gently without making bubbles in the incubator. Then, RGCs in
the supernatant were subjected quickly to flow cytometry. It took
approximately 3 to 4 minutes from cell avulsion to complete the
analysis for each culture well. The survival rate of RGCs was measured
quantitatively by the amount of fluorescence. The condition of the RGCs
was observed microscopically before and immediately after avulsion, and
no attached cells were confirmed on the culture dish.
Cells were evaluated using a flow cytometer (Facscaliber; Becton
Co., San Jose, CA). The measurement conditions were determined
from the preliminary experimental data as follows. Forward scatter
(FSC) value reflecting cell size: voltage E00, amplifier gain 2.3; side
scatter (SSC) value: reflecting cytoplasmic structure: voltage 400,
amplifier gain 2.0; and fluorescent intensity: voltage 450, amplifier
gain 1.5; flow rate: high. Ten thousand cells were evaluated in every
sample automatically. Two sizes of standard particles, 6 and 10 μm,
were measured to determine cell size before cell evaluation.
We confirmed the purification of RGC by recovery rate, morphologic
appearance, and retrograde labeling of isolated RGCs by DiI injection
from the superior colliculus.
1 2 3 The sizes and
distribution of both small and large RGCs classified in flow cytometry
were the same as those of RGCs on the culture dish or in previous
reports.
The evaluation of RGC survival using fluorescence intensity or
morphologic observation in the previous reports had a limit of
evaluated number of cells and took some time, during which the cell
conditions may have changed. Some reports evaluated RGC survival
according to the degree of process elongation.
3 However,
many cells with short processes were seen emitting strong fluorescence
of 5-chloromethylfluorescein diacetate, indicating that RGC survival
could not necessarily be evaluated accurately by measuring the length
of the process. It is not easy to draw the line accurately between
survived cell and nonsurvived cells by previous methods. The present
method can classify a total of 10,000 RGCs in approximately 2 minutes
per sample automatically by their cell size and fluorescence intensity.
Therefore, we believe that the present method evaluates cell conditions
much more objectively and accurately than previous methods. However,
the present method requires approximately twice the cell density needed
in previous methods.
1 2
In observations of RGCs under a fluorescent microscope before and after
avulsion, cells immediately after avulsion were found to be round with
a short process. However, the intensity of fluorescence did not change,
suggesting that there should be no problem in evaluating of cell
survival. In preliminary studies, we tried to use some enzymes to
dissociate and recover cells from the culture dish. In these cases,
however, cell viability was decreased and not suitable for evaluation.
The cell size of surviving cells was always slightly larger than
nonsurviving cells, either in the small-cell group or large-cell group
in the present study. Because it is well known that cells shrink their
cell body by apoptosis, nonsurviving cells in the present study were
thought to expire by apoptosis. Indeed, electron-microscopic
observations of currently isolated RGCs showed the condensation or
defragmentation of nuclei, which represent typical apoptotic changes
(data not shown).
In the present study, BDNF improved the survival rate
concentration-dependently, having nearly the same range as that
reported in previous studies. The maximum improvements of the survival
rates of small and large cells were 17.4% and 7.8%, respectively,
which seem to be lower than the values of previously reported in in
vivo studies.
17 Several explanations of this difference
are possible. Because previous studies were conducted by injection into
the hyaloid body or by coculture, the effects of unknown factors were
undeniable, and accurate quantitative analysis was difficult. Several
factors have neurotrophic effects on RGCs, and multiple factors should
be involved in neurotrophic action.
7 8 10 18 19 20 21 22 Indeed,
the number of RGCs in the BDNF knock-out mouse was the same as that of
the wild type.
19 23 In the present study, isolated RGCs
were cultured in a serum-free medium, eliminating the participation of
unknown factors. Second, the degree of improvement should differ
depending on cell type. Moreover, the maturity of RGCs may greatly
affect the results. Johnson et al.
6 reported that BDNF
rescued retinal neurons by 7% in E17 rat retina. However, this
improvement decreased in retinas of rats older than E17.
24 The number of trk-B receptors, a major BDNF receptor, was variable,
depending on retinal maturity.
25 26 27 28
It has been reported that rat RGCs can be classified into subgroups by
cell size, and those reactions against neurotoxic events or
neurotrophic factors were different depending on the cell
size.
7 15 Large RGCs were very resistant to axotomy in
adult rats.
7 The existence of trk-B receptors in retina is
well known.
25 26 28 29 Although many trk-B receptors exist
as a homodimers in the cell membrane, heterodimers composed of
truncated trk-B and full-length trk-B receptors have inhibitory effects
on BDNF signaling,
30 31 and those truncated trk-B
receptors were detected to a much greater extent in large RGCs than in
small RGCs in the adult rat.
31 The trk-B receptor is also
the major receptor for NT-4. This evidence may explain why the
improvements in the survival of large RGCs with BDNF or NT-4 was lower
than that for small RGCs in the present study.
The neuroprotective effects of NT-4 on RGCs are not necessarily
consistent.
5 8 11 12 The expression of NT-4 in the retina
is weaker than that of BDNF. This may be the reason why significant
neuroprotective effects of NT-4 on RGCs were not observed in the
present study. Because it was expected that the neurotrophic effects
should be clear when neurotoxic factors were challenged to the RGCs,
100 μM glutamate was administrated to RGCs with or without 100 ng/ml
of NT-4. Glutamate decreased the survival rate in both small and large
RGCs. However, the improvement of survival rate by NT-4 was not
significant (data not shown). Overall, it is implied that the
neuroprotective effect of NT-4 on RGCs is weaker than that of BDNF, at
least in the postnatal rat in vitro model.
In addition to BDNF and NT-4, several other neuroprotective factors
have been reported such as nerve growth factor (NGF), NT-3, and NT-6,
ciliary neurotrophic factor (CNTF), basic-fibroblast growth factor
(b-FGF). On the other hand, many neurotoxic factors like glutamate have
been discovered. Using the current experimental system, the effects of
various neuroprotective and neurotoxic factors on RGCs can be evaluated
objectively and accurately.
Supported by Grant 11307036 from the Japanese Minister of Health and Welfare (KK).
Submitted for publication November 3, 1999; revised February 9, 2000; accepted March 8, 2000.
Commercial relationships policy: N.
Corresponding author: Kenji Kashiwagi, Department of Ophthalmology, Yamanashi Medical University, 1110 Shimokato, Tamaho, Yamanashi 409-3898, Japan.
[email protected]
Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron
. 1988;1:791–803.
[CrossRef] [PubMed]Lindsey JD, Weinreb RN. Survival and differentiation of purified retinal ganglion cells in a chemically defined microenvironment. Invest Ophthalmol Vis Sci
. 1994;35:3640–3648.
[PubMed]Otori Y, Wei JY, Barnstable CJ. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci
. 1998;39:972–981.
[PubMed]Monard D, Solomon F, Rentsch M, Gysin R. Glia-induced morphological differentiation in neuroblastoma cells. Proc Natl Acad Sci USA
. 1973;70:1894–1897.
[CrossRef] [PubMed]Atkinson J, Panni MK, Lund RD. Effects of neurotrophins on embryonic retinal outgrowth. Brain Res Dev Brain Res
. 1999;112:173–180.
[CrossRef] [PubMed]Johnson JE, Barde YA, Schwab M, Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci
. 1986;6:3031–3038.
[PubMed]Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res
. 1993;602:304–317.
[CrossRef] [PubMed]Sawai H, Clarke DB, Kittlerova P, Bray GM, Aguayo AJ. Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells. J Neurosci
. 1996;16:3887–3894.
[PubMed]Frade JM, Bovolenta P, Martinez-Morales JR, et al. Control of early cell death by BDNF in the chick retina. Development
. 1997;124:3313–3320.
[PubMed]Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA
. 1994;91:1632–1636.
[CrossRef] [PubMed]Cohen A, Bray GM, Aguayo AJ. Neurotrophin-4/5 (NT-4/5) increases adult rat retinal ganglion cell survival and neurite outgrowth in vitro. J Neurobiol
. 1994;25:953–959.
[CrossRef] [PubMed]Cui Q, Harvey AR. NT-4/5 reduces naturally occurring retinal ganglion cell death in neonatal rats. Neuroreport
. 1994;5:1882–1884.
[CrossRef] [PubMed]Spalding KL, Cui Q, Harvey AR. The effects of central administration of neurotrophins or transplants of fetal tectal tissue on retinal ganglion cell survival following removal of the superior colliculus in neonatal rats. Brain Res Dev Brain Res
. 1998;107:133–142.
[CrossRef] [PubMed]Watanabe M, Sawai H, Fukuda Y. Survival of axotomized retinal ganglion cells in adult mammals. Clin Neurosci
. 1997;4:233–239.
[PubMed]Fukuda Y. A three-group classification of rat retinal ganglion cells: histological and physiological studies. Brain Res
. 1977;119:327–334.
[CrossRef] [PubMed]Politi LE, Lehar M, Adler R. Development of neonatal mouse retinal neurons and photoreceptors in low density cell culture. Invest Ophthalmol Vis Sci
. 1988;29:534–543.
[PubMed]Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science
. 1994;263:1618–1623.
[CrossRef] [PubMed]von Bartheld CS. Neurotrophins in the developing and regenerating visual system. Histol Histopathol
. 1998;13:437–459.
[PubMed]Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature
. 1994;368:147–150.
[CrossRef] [PubMed]Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell
. 1994;76:989–999.
[CrossRef] [PubMed]Conover JC, Erickson JT, Katz DM, et al. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature
. 1995;375:235–238.
[CrossRef] [PubMed]Liu X, Ernfors P, Wu H, Jaenisch R. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature
. 1995;375:238–241.
[CrossRef] [PubMed]Cellerino A, Carroll P, Thoenen H, Barde YA. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci
. 1997;9:397–408.
[CrossRef] [PubMed]Castillo B, Jr, del Cerro M, Breakefield XO, et al. Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). Brain Res
. 1994;647:30–36.
[CrossRef] [PubMed]Llamosas MM, Cernuda-Cernuda R, Huerta JJ, Vega JA, Garcia-Fernandez JM. Neurotrophin receptors expression in the developing mouse retina: an immunohistochemical study. Anat Embryol (Berl)
. 1997;195:337–344.
[CrossRef] [PubMed]Rickman DW, Brecha NC. Expression of the proto-oncogene, trk, receptors in the developing rat retina. Vis Neurosci
. 1995;12:215–222.
[CrossRef] [PubMed]Perez MT, Caminos E. Expression of brain-derived neurotrophic factor and of its functional receptor in neonatal and adult rat retina. Neurosci Lett
. 1995;183:96–99.
[CrossRef] [PubMed]Jelsma TN, Friedman HH, Berkelaar M, Bray GM, Aguayo AJ. Different forms of the neurotrophin receptor trkB mRNA predominate in rat retina and optic nerve. J Neurobiol
. 1993;24:1207–1214.
[CrossRef] [PubMed]Koide T, Takahashi JB, Hoshimaru M, et al. Localization of trkB and low-affinity nerve growth factor receptor mRNA in the developing rat retina. Neurosci Lett
. 1995;185:183–186.
[CrossRef] [PubMed]Eide FF, Vining ER, Eide BL, et al. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci
. 1996;16:3123–3129.
[PubMed]Suzuki A, Nomura S, Morii E, Fukuda Y, Kosaka J. Localization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells. J Neurosci Res
. 1998;54:27–37.
[CrossRef] [PubMed]